Results 261 to 270 of about 447,676 (385)
Hepatitis E Virus Infection with Nonimmune Hemolytic Anemia [PDF]
Veena Zamvar +4 more
openalex +1 more source
Abstract Background Glucose‐6‐phosphate dehydrogenase (G6PD) deficiency impairs cellular redox balance through reduced NADPH production and is the most common enzymatic disorder‐causing anemia. Venetoclax combined with azacitidine (Ven‐Aza) targets leukemic stem cells by disrupting oxidative phosphorylation and inducing mitochondrial stress. This study
Shira Buchrits +7 more
wiley +1 more source
Microangiopathic Hemolytic Anemia and Thrombocytopenia in Patients With Cancer.
Jordan Morton, J. George
semanticscholar +1 more source
Successful Dostarlimab Rechallenge Following Pembrolizumab-Induced Autoimmune Hemolytic Anemia: A Case Report. [PDF]
Khamis Z +7 more
europepmc +1 more source
Hemolytic anemia after percutaneous coronary intervention (PCI): A case report
Yu Zhang +4 more
openalex +1 more source
Can We Really Believe This Platelet Count?
American Journal of Hematology, Volume 101, Issue 3, Page 566-567, March 2026.
James Manning +3 more
wiley +1 more source
Alloimmunization in autoimmune hemolytic anemia patient: The differential adsorption approach
Aseem Kumar Tiwari +6 more
openalex +1 more source
Tumor‐associated macrophages are the most abundant immune cells in the tumor microenvironment, driving malignant progression and treatment resistance. This review summarizes the protumor mechanisms of TAMs (including phagocytosis modulation, metabolic reprogramming, exosomal communication, and immune interactions), evaluates three major strategies ...
Wurihan Bao +8 more
wiley +1 more source
Immunotherapy-Associated Hemolytic Anemia with Pure Red-Cell Aplasia.
R. Nair, Shereen M. F. Gheith, S. Nair
semanticscholar +1 more source

